Literature DB >> 33482243

Treatment effect variability in brain stimulation across psychiatric disorders: A meta-analysis of variance.

Stephanie Homan1, Whitney Muscat2, Andrea Joanlanne2, Nikolaos Marousis3, Giacomo Cecere3, Lena Hofmann3, Ellen Ji3, Maria Neumeier3, Stefan Vetter3, Erich Seifritz3, Thomas Dierks4, Philipp Homan5.   

Abstract

Noninvasive brain stimulation methods such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are promising add-on treatments for a number of psychiatric conditions. Yet, some of the initial excitement is wearing off. Randomized controlled trials (RCT) have found inconsistent results. This inconsistency is suspected to be the consequence of variation in treatment effects and solvable by identifying responders in RCTs and individualizing treatment. However, is there enough evidence from RCTs that patients respond differently to treatment? This question can be addressed by comparing the variability in the active stimulation group with the variability in the sham group. We searched MEDLINE/PubMed and included all double-blinded, sham-controlled RCTs and crossover trials that used TMS or tDCS in adults with a unipolar or bipolar depression, bipolar disorder, schizophrenia spectrum disorder, or obsessive compulsive disorder. In accordance with the PRISMA guidelines to ensure data quality and validity, we extracted a measure of variability of the primary outcome. A total of 130 studies with 5748 patients were considered in the analysis. We calculated variance-weighted variability ratios for each comparison of active stimulation vs sham and entered them into a random-effects model. We hypothesized that treatment effect variability in TMS or tDCS would be reflected by increased variability after active compared with sham stimulation, or in other words, a variability ratio greater than one. Across diagnoses, we found only a minimal increase in variability after active stimulation compared with sham that did not reach statistical significance (variability ratio = 1.03; 95% CI, 0.97, 1.08, P = 0.358). In conclusion, this study found little evidence for treatment effect variability in brain stimulation, suggesting that the need for personalized or stratified medicine is still an open question.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Heterogeneity in treatment response; Noninvasive brain stimulation; Obsessive–compulsive disorder; Personalized treatment; Schizophrenia spectrum disorder; Transcranial direct current stimulation; Transcranial magnetic stimulation; Unipolar and bipolar depression

Mesh:

Year:  2021        PMID: 33482243     DOI: 10.1016/j.neubiorev.2020.11.033

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  5 in total

1.  Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysis.

Authors:  Robert A McCutcheon; Toby Pillinger; Orestis Efthimiou; Marta Maslej; Benoit H Mulsant; Allan H Young; Andrea Cipriani; Oliver D Howes
Journal:  World Psychiatry       Date:  2022-06       Impact factor: 79.683

2.  Change of Circulating Vascular Endothelial Growth Factor Level and Reduction of Anhedonia Are Associated in Patients With Major Depressive Disorder Treated With Repetitive Transcranial Magnetic Stimulation.

Authors:  Monika Elemery; Szilvia Kiss; Peter Dome; Laszlo Pogany; Gabor Faludi; Judit Lazary
Journal:  Front Psychiatry       Date:  2022-05-31       Impact factor: 5.435

3.  Superior temporal gyrus functional connectivity predicts transcranial direct current stimulation response in Schizophrenia: A machine learning study.

Authors:  Animesh Kumar Paul; Anushree Bose; Sunil Vasu Kalmady; Venkataram Shivakumar; Vanteemar S Sreeraj; Rujuta Parlikar; Janardhanan C Narayanaswamy; Serdar M Dursun; Andrew J Greenshaw; Russell Greiner; Ganesan Venkatasubramanian
Journal:  Front Psychiatry       Date:  2022-08-05       Impact factor: 5.435

4.  Repetitive transcranial magnetic stimulation for psychiatric symptoms in long-term hospitalized veterans with schizophrenia: A randomized double-blind controlled trial.

Authors:  Xiuru Su; Long Zhao; Yujie Shang; Yingnan Chen; Xiaowen Liu; Xuan Wang; Meihong Xiu; Huijing Yu; Lijun Liu
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

5.  Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.

Authors:  Maria S Neumeier; Stephanie Homan; Stefan Vetter; Erich Seifritz; John M Kane; Maximilian Huhn; Stefan Leucht; Philipp Homan
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.